GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

FDA Rejects BioMarin Pharmaceuticals’ Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
2020-08-20
Genentech’s IL-6 Inhibitor Bags FDA Approval for Neuromyelitis Optica Spectrum Disorder
2020-08-19
Mammoth Biosciences Signs Deal with UC Berkeley for Novel Micro CRISPR Protein
2020-08-16
Seres Therapeutics’ Microbiome Therapy for Recurrent C. difficile Infections, Shines in Phase 3
2020-08-12
Teladoc Health, Livongo Join Hands for Global Healthcare Delivery, Access, and Experience
2020-08-09
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
UCB Joins Forces with Roche to Develop Antibody Treatment for Alzheimer’s
2020-07-31
COVID-19: Immunic, Inc. Begins Phase 2 Trial of IMU-838 in fusion with Oseltamivir
2020-07-30
Cas – CLOVER: A New Dawn in Genome Editing Technology
2020-07-13
Twist Bioscience, Takeda Partner to Advance Biologics Discovery
2020-07-12
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Pfizer and BioNTech’s COVID-19 Vaccine Shows Encouraging Results
2020-07-05
Merck’s Pneumonia Vaccine Candidate Blossoms in Phase 3 Trial
2020-06-28
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
Biogen’s SMA Drug, Spinraza Continues to Show Benefits in Pre-Symptomatic Patients
2020-06-14
1 4 5 6 7 8
Scroll to Top